|
||||||||||||||||||||||
General Assembly Invitation
|
||||||||||||||||||||||
|
||||||||||||||||||||||
Agenda Items
|
||||||||||||||||||||||
1 - Opening and constitution of Meeting Council,
|
||||||||||||||||||||||
2 - Authorizing Meeting Council to sign the Annual General Meeting Minutes,
|
||||||||||||||||||||||
3 - Review, discussion and approval of 2021 Annual Report,
|
||||||||||||||||||||||
4 - Review, discussion and approval of 2021 Independent Audit Report Summary,
|
||||||||||||||||||||||
5 - Review, discussion and approval of the year-end financial statements for the fiscal year 2021,
|
||||||||||||||||||||||
6 - Discussion and approval of dividend distribution proposal by the Board of Directors for the fiscal year 2021,
|
||||||||||||||||||||||
7 - Release of each member of the Board of Directors of liability related to activities of the Company during 2021,
|
||||||||||||||||||||||
8 - Extension of the term of office of Ms. Lale Ergin until the Annual General Meeting for 2024 in line with the subparagraph (g) of the Corporate Governance Principle article numbered 4.3.6 in the Corporate Governance Communiqué numbered II-17.1 of the Capital Markets Board, due to the expiration of the term of office of the Independent Board Member Ms. Lale Ergin,
|
||||||||||||||||||||||
9 - Election of Board Members in place of the Board Members whose term of office expired and determination of the term of office of the newly elected members,
|
||||||||||||||||||||||
10 - Discussion and approval of the rights of the members of the Board of Directors regarding remuneration, bonus, premium,
|
||||||||||||||||||||||
11 - Approval of the Independent Audit Company for the fiscal year 2022 recommended by the Board of Directors in accordance with the Company's related Audit Committee report pursuant to the Turkish Commercial Code and the regulations of the Capital Markets Board,
|
||||||||||||||||||||||
12 - Informing General Assembly about the donations granted during the fiscal year of 2021,
|
||||||||||||||||||||||
13 - Informing General Assembly about securities-pledges, mortgages and acquired incomes and benefits given in favour of third parties during the fiscal year of 2021,
|
||||||||||||||||||||||
14 - Informing General Assembly about transactions stated in principles 1.3.6 and 1.3.7 (Annex -1) of Capital Markets Board's Corporate Governance Communique no II.17.1,
|
||||||||||||||||||||||
15 - Informing General Assembly regarding transactions with related parties in 2021,
|
||||||||||||||||||||||
16 - Granting authorization to the Chairman and Members of the Board to make transactions written in articles 395 and 396 of Turkish Commercial Code,
|
||||||||||||||||||||||
17 - Response to questions asked by shareholders.
|
||||||||||||||||||||||
Corporate Actions Involved In Agenda
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
Additional Explanations
|
||||||||||||||||||||||
Information regarding 8th and 9th agenda items are updated.
|
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.